Seminars in Hematology
Volume 40, Issue 4 , Pages 321-328 , October 2003

Genetic variation and hematology: single-nucleotide polymorphisms, haplotypes, and complex disease

  • Stephen Chanock

      Affiliations

    • Corresponding Author InformationAddress correspondence to Stephen J. Chanock, MD, Section of Genomic Variation, Pediatric Oncology Branch, National Cancer Institute, Advanced Technology Center, 8717 Grovemont Cir, Bethesda, MD 20892–4605, USA
    • Section on Genomic Variation, Pediatric Oncology Branch, and the Core Genotyping Facility, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

References 

  1. Abboud M, Laver J, Blau CA. Granulocytosis causing sickle-cell crisis. Lancet. 1998;351:959
  2. Ameyaw MM, Collie-Duguid ES, Powrie RH, et al.  Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet. 1999;8:367–370
  3. Black AJ, McLeod HL, Capell HA, et al.  Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med. 1998;129:716–718
  4. Botstein D, Risch N. Discovering genotypes underlying human phenotypes (past successes for mendelian disease, future approaches for complex disease). Nat Genet. 2003;33(suppl):228–237
  5. Brookes AJ. Rethinking genetic strategies to study complex diseases. Trends Mol Med. 2001;7:512–516
  6. Cargill M, Altshuler D, Ireland J, et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999;22:231–238
  7. Carroll JE, McKie V, Kutlar A. Are sickle cell disease patients with stroke genetically predisposed to the event by inheriting a tendency to high tumor necrosis factor levels?. Am J Hematol. 1998;58:250
  8. Chanock S, Taylor JG. Using genetic variation to study immunomodulation. Curr Opin Pharmacol. 2002;2:463–469
  9. Chanock SJ, Foster CB. SNPing away at innate immunity. J Clin Invest. 1999;104:369–370
  10. Chanock S, Wacholder S. One gene and one outcome? No way. Trends Mol Med. 2002;8:266–269
  11. Chanock S. Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Dis Markers. 2001;17:89–98
  12. Choi EH, Foster CB, Taylor JG, et al.  Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J Infect Dis. 2003;187:1153–1156
  13. Choi EH, Lee HJ, Yoo T, et al.  A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis. 2002;186:1207–1211
  14. Clayton D, McKeigue PM. Epidemiological methods for studying gene and environmental factors in complex diseases. Lancet. 2001;358:1356–1360
  15. Collie-Duguid ES, Pritchard SC, Powrie RH, et al.  The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics. 1999;9:37–42
  16. Collins FS, Guyer MS, Charkravarti A. Variations on a theme (Cataloging human DNA sequence variation). Science. 1997;278:1580–1581
  17. Collins A, Lonjou C, Morton NE. Genetic epidemiology of single-nucleotide polymorphisms. Proc Natl Acad Sci USA. 1999;96:15173–15177
  18. Collins FS, Green ED, Guttmacher AE, et al.  A vision for the future of genomics research. Nature. 2003;422:835–847
  19. Collins FS. Shattuck lecture—Medical and societal consequences of the Human Genome Project. N Engl J Med. 1999;341:28–37
  20. Daly MJ, Rioux JD, Schaffner SF, et al.  High-resolution haplotype structure in the human genome. Nat Genet. 2001;29:229–232
  21. Davies SM, Bhatia S, Ross JA, et al.  Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood. 2002;100:67–71
  22. Dervieux T, Blanco JG, Krynetski EY, et al.  Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells. Cancer Res. 2001;61:5810–5816
  23. Duan J, Wainwright MS, Comeron JM, et al.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003;12:205–216
  24. Dumur CI, Dechsukhum C, Ware JL, et al.  Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics. 2003;81:260–269
  25. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995;12:921–927
  26. Fallin D, Cohen A, Essioux L, et al.  Genetic analysis of case/control data using estimated haplotype frequencies (Application to APOE locus variation and Alzheimer’s disease). Genome Res. 2001;11:143–151
  27. Foster CB, Lehrnbecher T, Mol F, et al.  Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998;102:2146–2155
  28. Gabolde M, Guilloud-Bataille M, Feingold J, et al.  Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis (Cohort study). BMJ. 1999;319:1166–1167
  29. Gabriel SB, Schaffner SF, Nguyen H, et al.  The structure of haplotype blocks in the human genome. Science. 2002;296:2225–2229
  30. Garred P, Pressler T, Lanng S, et al.  Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol. 2002;33:201–207
  31. Garred P, Pressler T, Madsen HO, et al.  Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. 1999;104:431–437
  32. Garred P, Voss A, Madsen HO, et al.  Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun. 2001;2:442–450
  33. Glatt CE, DeYoung JA, Delgado S, et al.  Screening a large reference sample to identify very low frequency sequence variants (Comparisons between two genes). Nat Genet. 2001;27:435–438
  34. Halushka MK, Fan JB, Bentley K, et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet. 1999;22:239–247
  35. Hirschhorn JN, Lohmueller K, Byrne E, et al.  A comprehensive review of genetic association studies. Genet Med. 2002;4:45–61
  36. Hoal-Van Helden EG, Epstein J, Victor TC, et al.  Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res. 1999;45:459–464
  37. Hoppe C, Klitz W, Noble J, et al.  Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood. 2003;101:2865–2869
  38. Hoppe C, Cheng S, Grow M, et al.  A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. Br J Haematol. 2001;114:718–720
  39. Hoque MO, Lee CC, Cairns P, et al.  Genome-wide genetic characterization of bladder cancer (A comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis). Cancer Res. 2003;63:2216–2222
  40. Infante-Rivard C, Amre D, Sinnett D. GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water (Effect on childhood leukemia). Environ Health Perspect. 2002;110:591–593
  41. Innocenti F, Iyer L, Ratain MJ. Pharmacogenetics (A tool for individualizing antineoplastic therapy). Clin Pharmacokinet. 2000;39:315–325
  42. Johnson GC, Esposito L, Barratt BJ, et al.  Haplotype tagging for the identification of common disease genes. Nat Genet. 2001;29:233–237
  43. Krajinovic M, Labuda D, Sinnett D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics. 2002;12:655–658
  44. Krajinovic M, Sinnett H, Richer C, et al.  Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer. 2002;97:230–236
  45. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet. 2001;27:234–236
  46. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet. 1999;22:139–144
  47. Lander ES, Linton LM, Birren B, et al.  Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921
  48. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 2000;95:1517–1532
  49. Lindblad-Toh K, Tanenbaum DM, Daly MJ, et al.  Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol. 2000;18:1001–1005
  50. Lohmueller KE, Pearce CL, Pike M, et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177–182
  51. McLeod HL, Lin JS, Scott EP, et al.  Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther. 1994;55:15–20
  52. McLeod HL, Evans WE. Pharmacogenomics (Unlocking the human genome for better drug therapy). Annu Rev Pharmacol Toxicol. 2001;41:101–121
  53. McLeod HL, Pritchard SC, Githang’a J, et al.  Ethnic differences in thiopurine methyltransferase pharmacogenetics (Evidence for allele specificity in Caucasian and Kenyan individuals). Pharmacogenetics. 1999;9:773–776
  54. Mullighan CG, Heatley S, Doherty K, et al.  Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood. 2002;99:3524–3529
  55. Neth O, Hann I, Turner MW, et al.  Deficiency of mannose-binding lectin and burden of infection in children with malignancy (A prospective study). Lancet. 2001;358:614–618
  56. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.  Cerebrovascular accidents in sickle cell disease (rates and risk factors). Blood. 1998;91:288–294
  57. Orkin SH, Kazazian HH, Antonarakis SE, et al.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature. 1982;296:627–631
  58. Peterslund NA, Koch C, Jensenius JC, et al.  Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet. 2001;358:637–638
  59. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet. 2001;69:124–137
  60. Rieder MJ, Taylor SL, Clark AG, et al.  Sequence variation in the human angiotensin converting enzyme. Nat Genet. 1999;22:59–62
  61. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–1517
  62. Risch N. The genetic epidemiology of cancer (Interpreting family and twin studies and their implications for molecular genetic approaches). Cancer Epidemiol Biomarkers Prev. 2001;10:733–741
  63. Risch NJ. Searching for genetic determinants in the new millennium. Nature. 2000;405:847–856
  64. Roses AD. Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov. 2002;1:541–549
  65. Rothman N, Wacholder S, Caporaso NE. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta. 2001;1471:C1–C10
  66. Schaid DJ, Rowland CM, Tines DE, et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425–434
  67. Stram D, Haiman C, Hirschhorn J, et al.  Chosing haplotype-tagging SNP based on unphased genotype data using a preliminary sample of the unrelated subjects with an example from the multiethnic cohort study. Human Hered. 2003;55:27–36
  68. Takeuchi S, Tsukasaki K, Bartram CR, et al.  Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia. Leukemia. 2003;7:149–154
  69. Taylor JG, Choi EH, Foster CB, et al.  Using genetic variation to study human disease. Trends Mol Med. 2001;7:507–512
  70. Taylor JG, Tang DC, Savage SA, et al.  Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood. 2002;100:4303–4309
  71. Taylor JG, Tang D, Foster CB, et al.  Patterns of low-affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell disease. Am J Hematol. 2002;69:109–114
  72. Venter JC, Adams MD, Myers EW, et al.  The sequence of the human genome. Science. 2001;16:1304–1351
  73. Wacholder S, Garcia-Closas M, Rothman N. Study of genes and environmental factors in complex diseases. Lancet. 2002;359:1155
  74. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics (Monogenic inheritance of erythrocyte thiopurine methyltransferase activity). Am J Hum Genet. 1980;32:651–662
  75. Winkelstein JA, Marino MC, Johnston RB, et al.  Chronic granulomatous disease (Report on a national registry of 368 patients). Medicine (Baltimore). 2000;79:155–169
  76. Zhang S, Zhao H. Linkage disequilibrium mapping in populations of variable size using the decay of haplotype sharing and a stepwise-mutation model. Genet Epidemiol. 2000;19(suppl 1):S99–S105

PII: S0037-1963(03)00198-7

doi: 10.1016/S0037-1963(03)00198-7

Seminars in Hematology
Volume 40, Issue 4 , Pages 321-328 , October 2003

Article Tools